Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P2.03-010 - Updated Survival Outcomes of NEJ005/TCOG0902, a Randomized PII of Gefitinib and Chemotherapy in EGFR-Mutant NSCLC
09:30 - 09:30 | Presenter: Tatsuro Fukuhara | Author(s): S. Oizumi, S. Sugawara, K. Minato, T. Harada, A. Inoue, Y. Fujita, Satoshi Watanabe, K. Ito, Akihiko Gemma, Y. Demura, M. Harada, H. Isobe, I. Kinoshita, S. Morita, Kunihiko Kobayashi, K. Hagiwara, M. Kurihara, T. Nukiwa
- Abstract
Loading... -
+
P2.03-021 - A Phase I Study Evaluating the Combination of Afatinib, Carboplatin and Pemetrexed after Failure of 1St Generation EGFR-TKIs
09:30 - 09:30 | Presenter: Ou Yamaguchi | Author(s): Satoshi Watanabe, A. Masumoto, Y. Maeno, Y. Kawashima, O. Ishimoto, S. Sugawara, H. Yoshizawa, Kunihiko Kobayashi, T. Nukiwa
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-035 - Post-Marketing Observational Study of Japanese Patients with EGFR Mutation-Positive (EGFRm+) NSCLC Treated with Daily Afatinib (Final Report)
09:30 - 09:30 | Presenter: Nobuyuki Yamamoto | Author(s): T. Nukiwa, Yoichi Nakanishi, Akihiko Gemma, M. Mizushima, T. Takayama, J. Kumazawa, H. Azuma, K. Tamura
- Abstract
Loading...